new post
StocksRunner logo
mail
search
 
menu
 
Amicus Therapeutics
$10.41
+8.79%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

FOLD Stock Analysis & IQ Rating | Amicus Therapeutics

 
 
 

FOLD

 

Amicus Therapeutics

$10.41

 
+$0.85 | +8.79%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$10.4
 
 
MKT CAP
$2.95B
 
52W Low
$5.51
 
 
VOL
$57.95K
 
P/E Ratio
N/A
 
 
AVG VOL
$4.78M
 
RSI
75.50
 
 
TREND
Uptrend
 
 
 

FOLD Stock IQ

 
lock  Login to see Amicus Therapeutics (FOLD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

FOLD Target Price

 
 
 

Strengths

 

FOLD Rewards

 Earnings are forecast to grow

 
 

Chart

 
 

$8.86   (+17.49%)

$7.59   (+37.15%)

$6.1   (+70.66%)

$9.74   (+6.88%)

 
 
1year
6month
3month
1month
 

FOLD Risk Level

 

FOLD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 
 
FOLD Risk Level
Low
LOW
HIGH
 

FOLD Analysts Opinion

 

FOLD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

FOLD Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

FOLD Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

FOLD Future Sentiment

 Earnings are forecast to grow

 
 

FOLD Analysts Opinion

FOLD Analysts opinion is positive but there was a setback from the past 3 months

 

FOLD Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
71%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
50%
NA
100%
 

FOLD Street Sentiment 

FOLD Street Sentiment is bullish and have positive views on the near-term outlook

 

FOLD Performance Sentiment

 
Sentiments overview associated with FOLD events and the stock performance.
 
71%
21%
Positive
Negative
10 out of 14
events present
3 out of 14
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$9.56
 
Resistance
Price
 
$8.50
 
 
Current Price Range
 
$9.73
 
 
Show methods +
 
 
Linked to FOLD
IQ
Close Price
Change
 

SNY

4.02

49.57

-0.10%

 

PFE

3.94

25.14

+0.36%

 
 
 
FOLD Latest Analysis +
 
 
FAQ About FOLD Stock Insights
 

What is FOLD current stock price?

What are FOLD stock strengths?

What is FOLD Risk Level?

What is FOLD market cap and volume?

What is FOLD current Stock IQ?

Should I buy FOLD stock right now?

Is FOLD a Strong Buy right now?

What does a 'Strong Buy' rating mean for FOLD?

What does a 'Strong Sell' rating mean for FOLD?

What factors influence FOLD's Stock IQ?

 
 
StocksRunner

Explore our FOLD Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FOLD Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our FOLD Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 

FOLD

 

Amicus Therapeutics

 
 

Current Price

 

$10.41

 
+$0.85 | +8.79%
 
 
52W High
$10.4
 
 
MKT CAP
$2.95B
 
52W Low
$5.51
 
 
VOL
$57.95K
 
P/E Ratio
N/A
 
 
AVG VOL
$4.78M
 
RSI
75.50
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

FOLD Rewards

 Earnings are forecast to grow

 
 
 

Linked to FOLD

 
 
 
Symbol
IQ
Close
Change
 

SNY

4.02

49.57

-0.10%

 

PFE

3.94

25.14

+0.36%

 
 
 
 
 
user
 
 
 
 
 

FOLD Stock IQ

 
lock  Login to unlock Amicus Therapeutics (FOLD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$8.86   (+17.49%)

$7.59   (+37.15%)

$6.1   (+70.66%)

$9.74   (+6.88%)

 
 
1year
6month
3month
1month
 

FOLD Analysts Opinion

 

FOLD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

FOLD Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

FOLD Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

FOLD Future Sentiment

 Earnings are forecast to grow

 
 

FOLD Analysts Opinion

FOLD Analysts opinion is positive but there was a setback from the past 3 months

 

FOLD Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
71%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
50%
NA
100%
 

FOLD Street Sentiment 

FOLD Street Sentiment is bullish and have positive views on the near-term outlook

 

FOLD Risk Level

 

FOLD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 
 
FOLD Risk Level
Low
LOW
HIGH
 
FOLD Performance Sentiment
 
Sentiments overview associated with FOLD events and the stock performance.
 
71%
21%
Positive
Negative
10 out of 14
events present
3 out of 14
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$9.56
 
Resistance
Price
 
$8.50
 
 
Current Price Range
 
$9.73
 
 
Show methods +
 
 
 
 
 
 

FOLD Latest Analysis

 
 
 

Goldman Sachs ish on Amicus Therapeutics (FOLD) Following Q3 2025 Results. With significant upside potential and hedge fund interest Amicus Therapeutics Inc. (NASDAQ:FOLD) secured a spot on our list of the 15 stocks set to explode in 2026. On November 5 2025 Goldman Sachs raised its price target on Amicus Therapeutics Inc. (NASDAQ:FOLD) from $9 to $11 maintaining a Neutral rating. The revision follows the companys [….]

 

Tue Nov 11, 2025

$9.32 | +3.61%
 
Potential
Rating

Amicus Therapeutics Inc. (FOLD) Presents at UBS Global Healthcare Conference 2025 Transcript.

 

Mon Nov 10, 2025

$9.00 | +1.47%
 
Activity

Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Heres is How to Trade. The consensus price target hints at a 76.3% upside potential for Amicus Therapeutics (FOLD). While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

 

Mon Nov 10, 2025

$9.00 | +1.47%
 
Potential

JP Morgan Maintains Amicus Therapeutics (FOLD) Overweight Recommendation. Fintel reports that on November 6 2025 JP Morgan maintained coverage of Amicus Therapeutics (NasdaqGM:FOLD) with a Overweight recommendation. Analyst Price Forecast Suggests 83.37% Upside

 

Fri Nov 7, 2025

$8.87 | -0.34%
 
Rating

Compared to Estimates Amicus Therapeutics (FOLD) Q3 Earnings: A Look at Key Metrics. Although the revenue and EPS for Amicus Therapeutics (FOLD) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

 

Wed Nov 5, 2025

$9.16 | +2.22%
 
Potential

Amicus Therapeutics Inc. (NASDAQ:FOLD) Q3 2025 Earnings Call Transcript. Amicus Therapeutics Inc. (NASDAQ:FOLD) Q3 2025 Earnings Call Transcript November 4 2025 Amicus Therapeutics Inc. misses on earnings expectations. Reported EPS is $0.06 EPS expectations were $0.12. Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics Third Quarter 2025 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder this conference [….]

 

Wed Nov 5, 2025

$9.16 | +2.22%
 
Earnings

Amicus Therapeutics (FOLD) Beats Q3 Earnings and Revenue Estimates. Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 41.67% and 2.61% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Tue Nov 4, 2025

$8.99 | +1.47%
 
Earnings

Amicus Therapeutics GAAP EPS of -$0.38 misses by $0.42 revenue of $14.5B beats by $14.33B.

 

Tue Nov 4, 2025

$8.99 | +1.47%
 
Earnings
Earnings

Amicus Therapeutics Non-GAAP EPS of $0.18 beats by $0.06 revenue of $169.06M beats by $3.35M.

 

Tue Nov 4, 2025

$8.99 | +1.47%
 
Earnings
 
 
 
 
 
StocksRunner

Discover FOLD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of FOLD. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our FOLD Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

FOLD Stock trends

FOLD Stock performance

FOLD Stock analysis

FOLD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

FOLD Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
 
×
 
0/666
joker
 
Post